Related Experiment Video
Updated: Nov 14, 2025

Isolation of Neonatal Extrahepatic Cholangiocytes
Published on: June 5, 2014
A Patient with neonatal cholestasis
Kristl G Claeys1,2, Luc Breysem3, Eric Legius4,5
1Department of Neurology, University Hospital Leuven, Leuven, Belgium.
Insights
This study identifies a novel pathogenic variant in the SLC7A2 gene associated with elevated arginine and lysine levels in a family. The findings contribute to understanding genetic contributions to amino acid metabolism disorders.
Area of Science:
- Genetics
- Metabolic Disorders
- Neurology
Background:
- McCune-Albright syndrome is a rare genetic disorder.
- Charcot-Marie-Tooth neuropathy is a group of inherited disorders.
- Gilbert syndrome is a common liver condition.
Purpose of the Study:
- To investigate the genetic basis of polyostotic fibrous dysplasia, Charcot-Marie-Tooth neuropathy, and amino acid level abnormalities in a patient and his family.
- To identify novel genetic variants contributing to these conditions.
Main Methods:
- Clinical examination and genetic analysis of the patient and his family members.
- Whole exome sequencing to identify pathogenic variants.
- Biochemical analysis of plasma amino acid levels.
Main Results:
- The patient presented with McCune-Albright syndrome, Charcot-Marie-Tooth neuropathy due to a DNM2 mutation, and Gilbert syndrome.
- A novel pathogenic SLC7A2 variant was identified in the patient and affected family members, correlating with increased plasma arginine and lysine levels.
Conclusions:
- The study highlights a novel SLC7A2 variant as a likely cause of familial hyperargininemia and hyperlysinemia.
- Genetic factors play a significant role in the complex phenotype observed in this family, including neurological and metabolic manifestations.
Abstract:
The patient, a boy born in 1991, showed pronounced polyostotic fibrous dysplasia due to McCune-Albright syndrome, as well as Gilbert syndrome and Charcot-Marie-Tooth neuropathy caused by a DNM2 mutation. In addition, the patient, his sister, mother and maternal grandfather had intermittently increased plasma arginine and lysine levels, most probably due to heterozygosity for a novel pathogenic SLC7A2 variant.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Distribution
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Chronic Pancreatitis II: Collaborative Care
Assessment:

